98%
921
2 minutes
20
Objective: To explore new metrics for assessing radical prostatectomy difficulty through a two-stage deep learning method from preoperative magnetic resonance imaging.
Methods: The procedure and metrics were validated through 290 patients consisting of laparoscopic and robot-assisted radical prostatectomy procedures from two real cohorts. The nnUNet_v2 adaptive model was trained to perform accurate segmentation of the prostate and pelvis. A modified network PointNet was used for indirectly regressing 15 anatomical landmarks based on Gaussian heatmaps. Novel metrics proposed in this study that characterized the spatial relationship between the prostate and pelvis were included to evaluate the surgical difficulty.
Results: The two-stage process achieved decent segmentation and landmark localization results with the mean validation dice of 0.8641 and millimeter-level accuracy. We found the coefficients of PV, ρ, PT, PAP, AG, PSD, PSD, πρ/ISTA, AG+PG, AG×PG, PSD×ρ, and PAP/(AG+PG) with Estimated Blood Loss and PSD, PSD×ρ with Operation Time, respectively, with statistic significant, which provides possibilities for assessing surgical difficulty evaluation. The entire pipeline had been validated on the external dataset, and the results were consistent.
Conclusion: The two-stage anatomical landmark localization approach is feasible. Indicators describing pelvic-prostate spatial constraints significantly impact surgical difficulty in radical prostatectomy, leading to increased blood loss and longer operation times, while isolated pelvic measurements have minimal effect on surgical outcomes.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.urology.2025.01.028 | DOI Listing |
Prostate
September 2025
Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montréal Health Center, Montréal, Québec, Canada.
Background: The USPSTF recommendation against PSA screening (RAPS) in 2012 resulted in unfavorable changes in prostate cancer (PCa) outcomes. However, the effect on cancer-specific mortality (CSM) in localized PCa has not been assessed.
Methods: Within the Surveillance, Epidemiology, and End Results database (2004-2021), we identified patients treated with radiotherapy (RT) or radical prostatectomy (RP) for localized PCa.
J Cancer Res Clin Oncol
September 2025
Department of Urology, University Hospital Tübingen, Eberhard Karls University, Hoppe-Seyler Str. 3, 72076, Tübingen, Germany.
Introduction And Objectives: High socioeconomic status (SES) is associated with improved oncological outcomes across various cancer types, including prostate cancer. However, limited evidence exists regarding the impact of SES and lifestyle factors on patient-reported outcomes (PROs), including quality of life (QoL), health status (HS), and functional recovery following radical prostatectomy (RP).
Materials And Methods: We conducted a retrospective single-center analysis of 327 patients undergoing RP (177 open, 150 robotic-assisted) assessing pre- and postoperative functional outcomes (QoL, HS, erectile function, continence).
Nat Rev Urol
September 2025
Division of Cancer Surgery, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
Prostate Cancer Prostatic Dis
September 2025
Department of Urology, Department of Health Science, University of Milan, ASST Santi Paolo e Carlo, Milan, Italy.
Introduction: The introduction of novel robotic platforms has expanded surgical options for robot-assisted radical prostatectomy (RARP). However, comparative outcomes with da Vinci multiport (MP) system remain unclear. This systematic review and network meta-analysis aimed to compare perioperative, early oncological, and functional outcomes of RARP performed with novel robotic platforms versus the da Vinci MP system.
View Article and Find Full Text PDFAdv Urol
August 2025
Department of Urology, Graduate School of Medicine, Yamaguchi University, Ube, Yamaguchi, Japan.
In biochemically recurrent prostate cancer (BRPC), no definitive independent prognostic factors were reported. This study aimed to identify the factors impacting overall survival (OS) in patients with BRPC after radical prostatectomy (RP). Among 610 consecutive patients who underwent RP between January 2000 and December 2019, with follow-up through December 2024, 152 (25%) patients who developed BRPC were analyzed.
View Article and Find Full Text PDF